Cabaletta Bio financial statements

카발레타 바이오NASDAQ:CABA · Nasdaq · Healthcare · sector #16
$2.02-2.88%
2026-10-06 close · prelim

Cabaletta Bio's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$125M.

Reported results

Cabaletta Bio notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q